Pharmacovigilance Programme in Chile

Abstract

National Drug Information and Pharmacovigilance Centre (CENIMEF) is part of the Public Health Institute, the official regulatory agency on medicines. Chilean Pharmacovigilance Programme was established in April 1995 and was accepted in the WHO Drug Monitoring Centre in March 1996. Is on a voluntary basis by a reporting form/card, reporters are all health care professionals. WHO causality terms and definitions are used for adverse drug reaction (ADR) evaluation. From 1998 CENIMEF has organized and dictated workshops on pharmacovigilance for hospitals health care professionals all over the country. The challenge is keep improving the promotion of ADR reporting from health care professionals and include the pre-grade Pharmacovigilance teaching.